What Lies Beyond Health Reform: Pfizer's Kindler Talks Innovation, Jobs
This article was originally published in The Pink Sheet Daily
Executive Summary
PhRMA's incoming chairman, Pfizer CEO Jeff Kindler, is pushing redoubled efforts toward a public/private solution on advancing innovation within the U.S. biopharmaceutical industry. As the fate of health reform remains uncertain, he discusses over-arching goals and challenges for the industry in the year ahead.